Dean Smith became the fifth person to leave Big Brother on Friday night - but got stuck in the house due to a huge technical issue. Tense scenes saw the 35-year-old barber from East London say ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
Fintel reports that on October 31, 2024, Morgan Stanley downgraded their outlook for Biogen (SNSE:BIIBCL) from Overweight to Equal-Weight. There are 1,775 funds or institutions reporting positions ...
Healthcare analytics company PurpleLab joined the Network Advertising Initiative. Biogen and Neomorph announced a multi-target research collaboration to discover and develop molecular glue degraders ...
Biogen Inc. (NASDAQ:BIIB) the central nervous system disease drug developer based in Cambridge Massachusetts, reported its Q3 earnings yesterday, Wednesday, October 30. First, let's look at some ...
Matt Hardy and Jeff Hardy, The Hardy Boyz, became tag team champions again at TNA Wrestling's 2024 Bound For Glory event, winning a three-way Full Metal Mayhem match to win the TNA World Tag Team ...
Two days after Monte Rosa Therapeutics Inc. signed a molecular glue degrader deal with Novartis AG, two other companies, Biogen Inc. and Neomorph Inc., are moving forward in the same space in a ...
Biogen’s investors are growing restless. Wednesday’s third-quarter earnings call checked most of the boxes for a successful report. The company raised its full-year ...
Oct 30 (Reuters) - Biogen (BIIB.O), opens new tab raised its annual profit forecast on Wednesday, as new treatments and cost-cutting measures offset declining sales of its multiple sclerosis drugs.
DELE ALLI and Dean Henderson have joined mourners at the funeral of George Baldock. The former Sheffield United defender was found dead in the swimming pool of his Athens home on October 9.
Despite a somewhat ambling launch, Biogen’s Eisai-partnered Alzheimer’s disease drug Leqembi continues to grow. But to truly unlock the amyloid-busting antibody’s potential, the company will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback